Want to join the conversation?
$ECL narrowed its full year 2016 adjusted EPS guidance to $4.35-4.50 from prior forecast of $4.35-4.55, compared with full year 2015 adjusted EPS of $4.37. $ECL sees mid-single digit acquisition adjusted fixed currency sales growth in Institutional, Industrial and Other segments with about 10% decline in Global Energy segment sales.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?